Search - tctmd.com

Displaying 161 - 180 of 946

Sort: Relevancy | Date

News Daily News

Bajan los Índices de ACV y Aumentan las Dudas sobre los Dispositivos de Protección Embólica en las Intervenciones TAVR

Michael O'Riordan

March 14, 2016

News Daily News

As Stroke Rates Fall, Questions Mount for Embolic Protection Devices in TAVR

Michael O'Riordan

March 14, 2016

News Daily News

Risk Model Improves Practical Prediction of In-Hospital Mortality After TAVR

L.A. McKeown

March 08, 2016

News Industry News

LivaNova, PLC Announces the First U.S. Implants of Perceval, the Only Sutureless Valve for Aortic Valve Replacement Surgery

March 08, 2016

News Daily News

小组认为经颈动脉 TAVR 是可行的，且可取代经股动脉的其他替代方案

Shelley Wood

March 07, 2016

News Daily News

Un Grupo asegura que la TAVR Transcarotídea es Viable y Podría Reemplazar Otras Alternativas al Abordaje Transfemoral

Shelley Wood

March 07, 2016

News Daily News

Transcarotid TAVR Is Feasible, Could Supplant Other Alternatives to Transfemoral, Group Says

Shelley Wood

March 07, 2016

News Industry News

BioStable Science & Engineering Announces CE Mark Approval for the HAART 300 Aortic Annuloplasty Device

March 07, 2016

Presentation

Transcarotid Transcatheter Aortic Valve Replacement: Feasibility and Safety

Presenter: Darren Mylotte

March 06, 2016

News Industry News

Edwards SAPIEN XT Valve Receives FDA Approval For Pulmonic Procedures

March 01, 2016

News Daily News

Cardiac Surgery Risk Prediction with EuroSCORE Improved with Updated, Dynamic Modeling

Michael O'Riordan

March 01, 2016

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2016

Shelley Wood

February 28, 2016

News Industry News

LivaNova PLC Receives Regulatory Approval in Japan for the Solo Smart Stentless Tissue Aortic Valve

February 28, 2016

News Daily News

第 12 个月时女性的经导管主动脉瓣结局优于男性

Shelley Wood

February 23, 2016

News Daily News

Transcatheter Aortic Valve Outcomes Better in Women Than Men at 12 Months

Shelley Wood

February 23, 2016

News Daily News

Los Resultados de la Válvula Aórtica Transcatéter son Mejores en Mujeres que en Hombres a los 12 Meses

Shelley Wood

February 23, 2016

News Industry News

Medtronic Receives FDA Approval for Expanded Indication Trial in Low-Risk Aortic Stenosis Patients

February 21, 2016

News Daily News

FDA Gives Greenlight for Low-Risk TAVR Study With CoreValve

Michael O'Riordan

February 21, 2016

News Conference News CRT 2016

Early Results for Transcatheter Mitral Valve Replacement Reveal Complications and Challenges for the Long Road Ahead

Shelley Wood

February 21, 2016

News Daily News

Cardio-Oncology Offers Fellows the Opportunity to Venture Into the ‘Wild West’

L.A. McKeown

February 15, 2016

Advertisement

Bajan los Índices de ACV y Aumentan las Dudas sobre los Dispositivos de Protección Embólica en las Intervenciones TAVR

As Stroke Rates Fall, Questions Mount for Embolic Protection Devices in TAVR

Risk Model Improves Practical Prediction of In-Hospital Mortality After TAVR

LivaNova, PLC Announces the First U.S. Implants of Perceval, the Only Sutureless Valve for Aortic Valve Replacement Surgery

小组认为经颈动脉 TAVR 是可行的，且可取代经股动脉的其他替代方案

Un Grupo asegura que la TAVR Transcarotídea es Viable y Podría Reemplazar Otras Alternativas al Abordaje Transfemoral

Transcarotid TAVR Is Feasible, Could Supplant Other Alternatives to Transfemoral, Group Says

BioStable Science & Engineering Announces CE Mark Approval for the HAART 300 Aortic Annuloplasty Device

Transcarotid Transcatheter Aortic Valve Replacement: Feasibility and Safety

Edwards SAPIEN XT Valve Receives FDA Approval For Pulmonic Procedures

Cardiac Surgery Risk Prediction with EuroSCORE Improved with Updated, Dynamic Modeling

TCTMD’s Top 10 Most Popular Stories for February 2016

LivaNova PLC Receives Regulatory Approval in Japan for the Solo Smart Stentless Tissue Aortic Valve

第 12 个月时女性的经导管主动脉瓣结局优于男性

Transcatheter Aortic Valve Outcomes Better in Women Than Men at 12 Months

Los Resultados de la Válvula Aórtica Transcatéter son Mejores en Mujeres que en Hombres a los 12 Meses

Medtronic Receives FDA Approval for Expanded Indication Trial in Low-Risk Aortic Stenosis Patients

FDA Gives Greenlight for Low-Risk TAVR Study With CoreValve

Early Results for Transcatheter Mitral Valve Replacement Reveal Complications and Challenges for the Long Road Ahead

Cardio-Oncology Offers Fellows the Opportunity to Venture Into the ‘Wild West’

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content